Models of Alzheimer’s Disease
Access Status
Authors
Date
2014Type
Metadata
Show full item recordCitation
Source Title
ISBN
Collection
Abstract
Alzheimer’s disease (AD) is a major and increasing burden on families, communities, and national health budgets. Despite intensive and extended research, there is still widespread debate about its cause(s), and no effective treatments exist. Familial (inherited, mainly early onset) and sporadic (mainly late onset) forms of the disease exist, and it is uncertain to what extent they are related. Transgenic mouse models have dominated the investigation of this disease, but their validity can be questioned. Numerous alternative models exist that can provide valuable information on the molecular and cellular basis of AD. In this chapter, we review the various invertebrate, nonmammalian vertebrate, and mammalian models and how these have been used to investigate this disease. We examine the strengths and weaknesses of these various model systems. Of course, animal models never completely reflect the true nature of a human disease, but progress in understanding and finding preventative and ameliorative treatments for AD is hindered by the lack of a convincing hypothesis for the cause of this complex condition.
Related items
Showing items related by title, author, creator and subject.
-
Chaichana, Thanapong (2012)Coronary artery disease is the leading cause of death in advanced countries. Coronary artery disease tends to develop at locations where disturbed flow patterns occur, such as the left coronary artery. Haemodynamic change ...
-
Jiang, Zhenyu (2011)Genomics is a major scientific revolution in this century. High-throughput genomic data provides an opportunity for identifying genes and SNPs (singlenucleotide polymorphism) that are related to various clinical phenotypes. ...
-
Zomer, E.; Si, S.; Hird, T.; Liew, D.; Owen, A.; Tonkin, A.; Reid, Christopher; Ademi, Z. (2018)Aims: Peripheral artery disease affects 1.2% of the population globally and is associated with an increased risk of atherothrombotic cardiovascular events, major adverse limb events and mortality. The Cardiovascular ...